Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$191.51 - $216.16 $814,109 - $918,896
4,251 Added 15.48%
31,704 $6.73 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $562 - $618
3 Added 0.01%
27,453 $5.28 Million
Q1 2023

May 12, 2023

BUY
$127.59 - $203.08 $38,659 - $61,533
303 Added 1.12%
27,450 $5.56 Million
Q4 2022

Feb 13, 2023

SELL
$117.37 - $139.17 $251,523 - $298,241
-2,143 Reduced 7.32%
27,147 $3.49 Million
Q3 2022

Nov 03, 2022

BUY
$135.27 - $180.11 $96,041 - $127,878
710 Added 2.48%
29,290 $4.01 Million
Q2 2022

Aug 09, 2022

SELL
$108.81 - $179.33 $25,896 - $42,680
-238 Reduced 0.83%
28,580 $5.06 Million
Q1 2022

May 06, 2022

BUY
$119.61 - $157.85 $121,762 - $160,691
1,018 Added 3.66%
28,818 $4.15 Million
Q4 2021

Feb 08, 2022

BUY
$142.57 - $190.86 $462,782 - $619,531
3,246 Added 13.22%
27,800 $4.3 Million
Q3 2021

Nov 09, 2021

SELL
$142.45 - $169.82 $1.8 Million - $2.14 Million
-12,622 Reduced 33.95%
24,554 $4.17 Million
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $352,828 - $420,793
2,612 Added 7.56%
37,176 $5.87 Million
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $1.95 Million - $2.7 Million
14,156 Added 69.36%
34,564 $4.8 Million
Q4 2020

Feb 03, 2021

BUY
$164.63 - $211.93 $3.36 Million - $4.33 Million
20,408 New
20,408 $3.57 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.